Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Drug:  vatalanib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPTK787 0135/306241, CONFIRM 1, NCT00056459

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: 2004-0248, NCT00088231

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 69
Sponsor: Other
Protocol IDs: EORTC-26041-22041, EORTC-26041, EORTC-22041, EUDRACT-2004-003896-35, NCT00128700

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IRB-06999, 95533, CPTK787AUS08, PANC0002, NCT00185588

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPTK787 0134/306220, NCT00171587

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UKSH A-105, EudraCT No. 2005-002192-32, NCT00615160

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000269537, U10CA031946, CALGB-30107, NCT00053885

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000339810, U10CA031946, CALGB-10105, NCT00072475

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2005.014, NCT00134355

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: 03-257, NCT00165347

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91411, 2004-002290-22, 308801, NCT00160043

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: PCRT04-001, NCT00226005

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CPTK787 A2401/300267, GIST PTK787/ZK222584, NCT00117299

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 05C4, STU00005338, NU-1398-025, NOVARTIS-NU-05C4, NCT00348790

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CRCA-CCTC-CAMEL02, EU-20787, EUDRACT-2005-004710-33, CCTC-Camel-02, CCLG-Camel-02, ISRCTN191981, NCT00563823

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CPTK787/ZK222584, NCT00627198

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: AMC-016, NOVARTIS-CPTK7870104

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000386239, P30CA016042, UCLA-0403067-01, NOVARTIS-CPTK7870113, NCT00091299

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Pro00012347, DUMC-6626-04-12R0, CDR0000454988, NCT00303732

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 05-020, NCT00268918

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: Pro00006014, DUMC-7019-06-3R1, NOVARTIS-DUMC-7019-06-3R1, NCT00387933

22.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-046, NCT00358163

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC0515, NCI-2009-01316, P30CA015083, MAYO-MC0515, MAYO-06-002065, NOVARTIS-CPTK787AUS16, NCT00390000

24.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-013, NCT00385853

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC0414, NCI-2009-01200, P30CA015083, MAYO-MC0414, NCT00655655
New Search